Skip to main content
TipRanks
Go Ultimate75% OFF

Compare Novavax (NVAX) vs. Competitors

10,193 Followers

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
NVAXNovavax$7.47$1.23B-16.2420.10%HoldUnlock the NVAX analyst price target with TipRanks PremiumNVAXUnlock the NVAX top-analyst price target with TipRanks Premium
VIRVir Biotechnology$8.39$1.44B-6.7150.90%Strong BuyUnlock the VIR analyst price target with TipRanks PremiumNVAX vs VIRUnlock the VIR top-analyst price target with TipRanks Premium
ORICOric Pharmaceuticals$7.36$764.94M-5.04-35.89%Strong BuyUnlock the ORIC analyst price target with TipRanks PremiumNVAX vs ORICUnlock the ORIC top-analyst price target with TipRanks Premium
ABCLAbCellera Biologics$9.69$3.16B-20.19184.16%Strong BuyUnlock the ABCL analyst price target with TipRanks PremiumNVAX vs ABCLUnlock the ABCL top-analyst price target with TipRanks Premium
SANASana Biotechnology$1.59$476.42M-3.00-50.77%Strong BuyUnlock the SANA analyst price target with TipRanks PremiumNVAX vs SANAUnlock the SANA top-analyst price target with TipRanks Premium

Performance Comparison

-100%0%100%200%300%400%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
NVAXNovavax7.470.8412.67%
VIRVir Biotechnology8.392.2737.09%
ORICOric Pharmaceuticals7.36-4.43-37.57%
ABCLAbCellera Biologics9.696.12171.43%
SANASana Biotechnology1.59-1.95-55.08%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts